2HIDAKA T, SUZUKI K. Leukocytapheresis for rheumatic disease [J]. Ther Apher Dial, 2003, 7(2) : 161 -164.
3UEKI Y, YAMASAKI S, KANAMOTO Y, et al. Evaluation of filtration leukocytapheresis for use in the treatment of patients with rheumatoid arthritis[ J ]. Rheumatology(Oxford) , 2000, 39 ( 2 ) : 165 - 171.
4KEMPE K, TSUDA H, YANG K, et al. Filtration leukoeytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate[J]. Ther Apher Dial, 2004, 8(3) : 197 -205.
5YAMASAKI S, UEKI Y, NAKAMURA K, et al. Effect of filtration leukocytapheresis therapy: modulationof white blood cell enzyme activities in patients with rheumatoid arthritis [ J 1. Artificial Organs, 2002, 26(4): 378-384.
6UEKI Y, NAKAMURA H, KANAMOTO Y, et al. Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis[ J]. Ther Apher, 2001, 5(6) : 455 -461.
7LZUMI Y, TOMINAGA M, IWANAGA N, et al. Twenty - four -week follow - up examination of a leukoeytapheresis therapy in rheumatoid arthritis[ J ]. Mod Rheumatol, 2006, 16 ( 1 ) : 20 - 23.
8EGUCHI K, SAITO K, KONDO M, et al. Enhanced effect of high - dose leukocytapheresis using a large filter in rheumatoid arthritis[J]. Mod Rheumatol, 2007, 17 (6) : 481 - 485.
9SANMARTI R, MARSAL S, VALVERDE J, et al. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial[ J]. Rheumatology(Oxford), 2005, 44(9): 1140- 1144.
10TANAKA H, TSUGAWA K, NAKAHATA T, et al. Leukocytaphcresis for the treatment of refractory systemic - onset juvenile idiopathic arthritis[ J ]. Clin Rheumatol, 2007, 26 (6) : 101g - 1016.
